Introduction {#s1}
============

By December 2007, almost three million people living with HIV (PLWH) were estimated to be receiving antiretroviral therapy (ART) in low- and middle-income countries, representing 30% of the estimated population needing antiretrovirals (ARVs) in 2007. Sub-Saharan Africa is now estimated to have more than two million people on ART although four years ago there were 100,000 people on ART and coverage amounted to only 2% ([@R31]).

Zambia is one of the sub-Saharan African countries worst affected by the HIV pandemic. Adult HIV prevalence is about 14% and the number of PLWH is estimated to be 1.2 million ([@R7]). In August 2005, the Zambian Government announced free provision of ARVs to those who are in need in an attempt to achieve the national target of the "3 by 5" initiatives followed by the Universal Access targets. Out of the estimated 280,000 PLWH who are in need of ART, nearly half are believed to have used ART services prior to the end of 2007 ([@R29]). ART services have been expanded nationwide in Zambia and consequently ART has become increasingly accessible to PLWH in rural areas as well.

Given the living conditions in rural areas, the situation for PLWH in rural Zambia differs substantially from that in urban areas or in developed countries. Those differences should be taken into consideration to devise successful ART expansion programs.

ART adherence is now considered crucial for HIV-positive individuals receiving therapy and an important component for an ART program to succeed. Intervention strategies to support adherence have been found to be important in the achievement of positive outcomes ([@R1]). Consistently, high levels of adherence are needed for reliable viral suppression ([@R3]; [@R21]) and to prevent drug resistance ([@R2] [@R15]; [@R23]), disease progression ([@R4]), and death ([@R11]; [@R33]). Many factors, including complicated therapeutic regimens, depression, alcohol and drug use, and changes in daily routines may reportedly impact a patient\'s ability to adhere to these medications ([@R8]; [@R16]). In Zambia, several reports demonstrated factors associated with adherence in rural settings ([@R5]; [@R6]). However, no reports have examined more specific social issues in rural settings as factors influencing adherence to ART. Thus, this study investigated adherence to ART in rural settings in Zambia and assessed social and specific factors that may influence ART adherence in rural settings in order to help improve ART expansion strategies to better suit rural settings.

Methods {#s2}
=======

Study site {#s3}
----------

This study was conducted in Mumbwa District, which is located 150 km west of the capital and has a district hospital and 27 rural health centers, where the Ministry of Health has been expanding ART services. Among the health facilities, services were available only at the district hospital and four rural health centers that had approximately 2000 ART clients in total.

Study participants and procedures {#s4}
---------------------------------

Between 25 March and 25 April 2008, all ART clients aged 18 and over that came to the hospital or one of the four rural health centers where ART services were offered were asked to participate in the study. Prior to participation in the study, informed consent was obtained by trained interviewers.

A cross-sectional survey with a semi-structured questionnaire with face-to-face interviews was administered via trained interviewer in the local language. Interviewers were trained in the study protocol including questionnaire and the objectives of the study. Items on the questionnaire included: socio-demographic characteristics of the respondents; travel burden; support for adherence; the most frequently used method to remember when to take ARVs at scheduled times; ownership of a watch, a radio, or a mobile phone; and adherence to ART. In order to evaluate travel burden, time and cost for travel to the ART sites were asked. We asked time for only oneway trip, otherwise some respondents might include waiting time at clinics as travel time. Adherence was assessed by asking participants to report the number of ARV doses missed in the past four days. Participants reporting any missed dose were classified in the non-adherent group, while those reporting no missed doses were classified in the adherent group. In addition, respondents were asked about their perceived fear of stigma resulting from taking ARVs at home or work and feeling pressured to share ARVs with someone, conditions that were sometimes observed at the sites. The respondents verbally answered all the items and the interviewers recorded their answers. The respondents did not receive any financial profit but did receive a small gift such as cooking oil.

Data analysis {#s5}
-------------

Data were processed and analyzed in SPSS 15.0 for Windows. A logistic regression model was used to compute the relative risk of non-adherence, as indicated by missed doses in the past four days. A chi-square test was used to compare various independent variables in proportions when appropriate. The relative risks of possible factors were estimated by odds ratios (OR) and 95% confidence intervals (CI). In a multivariable logistic regression analysis, we included way to remember when to take ARVs since this variable could be a specific social factor to rural settings. And, independent variables that had a significant relationship with dependent variables at the *p* \<0.05 level were selected and included in the analysis.

Results {#s6}
=======

A total of 518 ART clients aged 18 and over from the hospital and the rural health centers were asked to participate in the study, and 518 (100%) agreed to respond to the questionnaire.

The mean age of the respondents was 38.3 years (range: 18--72 years) and the average months of treatment were 12.5 (range: 1--50 months) ([Table 1](#T1){ref-type="table"}). Of the 518 respondents, 206 (40%) were male, 251 (49%) were married or remarried, 266 (51%) were farmers, and 258 (50%) were treated by a rural health center. Two hundred and sixty-two respondents (51%) had a watch and 98 (19%) had a mobile phone. In order to access an ART service, 166 (32%) and 94 (18%) respondents spent more than two hours on one-way travel and more than 10,000 Kwacha (equivalent to 2.5 US\$) on the return trip.

Four hundred and fifty-eight respondents (88%) reported no missed doses during the last four days, while 502 (97%) of respondents endorsed "completely" when asked if they understood the need to take ARVs regularly at the same time. The most frequently reported ways to remember when to take ARVs were a watch (245, 47%) and a clock (79, 15%). Of note is the fact that 49 of the respondents (10%) reported using the position of the sun to remember when to take ARVs. Eighty-four (16%) perceived fear of stigma resulting from taking ARVs at home or work, and 49 (10%) had felt pressured to share ARVs with someone such as a family member or friend. About half of the respondents (51%) received support for adherence from their family members.

###### 

Characteristics of study respondents.

                                                                          Setting for ART                   
  ------------------------------------------------------ ---------------- ----------------- --------------- ---------
  Average age (year)                                     38.2 (9.2 SD)    38.0 (9.1 SD)     38.6 (9.3 SD)   −
  Gender                                                                                                    
    Male                                                 206 (39.8%)      112 (45.0%)       94 (37.0%)      0.069
    Female                                               297 (57.3%)      137 (55.0%)       160 (63.0%)     
  Marital status                                                                                            
    Single/Divorce/Widowed                               248 (47.9%)      129 (52.4%)       119 (47.0%)     0.227
    Married/Remarried                                    251 (48.5%)      117 (47.6%)       134             (53.0%)
  Occupation                                                                                                
    Government staff member                              18 (3.5%)        16 (6.5%)         2 (0.8%)        \<0.001
    Company employee                                     16 (3.1%)        12 (4.9%)         4 (1.7%)        
    Self-employed                                        68 (13.1%)       48 (19.6%)        20 (8.3%)       
    Farmer                                               266 (51.4%)      102 (41.6%)       164             (67.8%)
    Housewife                                            53 (10.2%)       21 (8.6%)         32 (13.2%)      
    Other                                                66 (12.7%)       46 (18.8%)        20 (8.3%)       
  Which do you own                                                                                          
    Watch                                                262 (50.6%)      138 (53.1%)       124 (48.1%)     0.254
    Mobile phone                                         98 (18.9%)       66 (55.0%)        32 (55.0%)      \<0.001
    Radio                                                254 (49.0%)      129 (49.6%)       125 (48.4%)     0.791
    Television set                                       109 (21.0%)      83 (55.0%)        26 (55.0%)      \<0.001
  Average treatment period (month)                       12.5 (10.3 SD)   15.2 (10.2 SD)    9.7 (9.7 SD)    
  Travel expenses for return trip                                                                           
    Free of charge                                       227 (43.8%)      83 (32.0%)        144 (56.7%)     \<0.001
    Less than 10,000 Kw                                  192 (37.1%)      101 (39.0%)       91 (35.8%)      
    More than 10,000 Kw                                  94 (18.1%)       75 (29.0%)        19 (7.5%)       
  Understanding of need to take ARVs                                                                        
    regularly at the same time                                                                              
    Yes, complete                                        502 (96.9%)      251 (96.5%)       251 (98.0%)     0.456
    Yes, but incomplete                                  10 (1.9%)        7 (2.7%)          3 (1.2%)        
    No                                                   6 (0.8%)         3 (0.8%)          3 (0.8%)        
  Way to remember when to take ARVs                                                                         
    Watch                                                245 (47.3%)      123 (47.5%)       122 (47.4%)     \<0.001
    Clock                                                79 (15.3%)       44 (16.9%)        35 (13.6%)      
    Mobile phone                                         58 (11.2%)       44 (16.9%)        14 (5.4%)       
    Radio/Television set                                 72 (13.9%)       20 (7.7%)         52 (20.2%)      
    Position of the sun                                  49 (9.5%)        20 (7.7%)         29 (11.3%)      
    Other                                                13 (2.5%)        8 (3.1%)          5 (1.9%)        
  Adherence support                                                                                         
    None                                                 99 (19.1%)       69 (26.5%)        30 (11.7%)      \<0.001
    Family                                               264 (51.0%)      137 (52.7%)       127 (49.6%)     
    Other                                                153 (29.7%)      54 (20.8%)        99 (38.7%)      
  Perceived stigma of taking ARVs                                                                           
    Never experienced stigma                             432 (83.7%)      202 (78.0%)       230 (89.5%)     \<0.001
    Experienced stigma                                   84 (16.3%)       57 (22.0%)        27 (10.5%)      
  Felt pressured to share ARVs                                                                              
    Never pressured                                      466 (90.5%)      230 (88.8%)       236 (92.2%)     0.191
    Felt pressured                                       49 (9.5%)        29 (11.2%)        20 (7.8%)       
  Recent Adherence (missed dose in the past four days)                                                      
    Never missed                                         458 (88.4%)      233 (90.7%)       225 (88.6%)     0.441
    One or more                                          53 (10.2%)       24 (9.3)          29 (11.4%)      

Bivariate analysis indicated that a younger age, i.e., 38 years or younger (OR = 2.5, 95% CI: 1.3--4.8, *p* = 0.005), and higher travel expenses (OR = 2.3, 95% CI: 1.1--4.8, *p* = 0.022), were associated with being classified in the non-adherent group ([Table 2](#T2){ref-type="table"}). Perceived fear of stigma resulting from taking ARVs at home or work (OR = 2.3, 95% CI: 1.2 to 4.5, *p* = 0.011) and feeling pressured to share ARVs with someone (OR = 5.7, 95% CI: 2.9 to 11.4, *p* \< 0.001) were also significantly associated with being classified in the non-adherent group. In contrast, support for adherence from family related to lower odds of being classified in the non-adherence group in comparison to some other form of support or no support (OR = 0.4, 95% CI: 0.2--0.9, *p* \<0.001).

Multivariable logistic regression analysis was performed with age, cost of the return trip, support for adherence, ways to remember when to take ARVs, perceived fear of stigma resulting from taking ARVs, and feeling pressured to share ARVs with someone ([Table 3](#T3){ref-type="table"}). A multivariable model demonstrated that age (38 or less; OR = 2.6, 95% CI: 1.3--5.5, *p* = 0.009), ways to remember when to take ARVs (the position of the sun) (OR = 3.3, 95% CI: 1.3--8.8, *p* = 0.016), and feeling pressured to share ARVs with someone (OR = 4.4, 95% CI: 1.6--12.0, *p* = 0.004) were significantly associated with membership in the non-adherent group.

We also found a high association between feeling pressured to share ARVs and perceived fear of stigma (OR = 20.7, 95% CI: 10.4--41.2, *p* \<0.001) and between higher travel expenses and perceived fear of stigma (OR = 1.4, 95% CI: 1.1--1.7, *p* = 0.001).

Discussion {#s7}
==========

The current study investigated social factors and considered possible conditions affecting the daily lives of patients on ART in rural areas, as well as socio-demographic characteristics related to ART adherence in rural Zambia. Findings demonstrated that age (38 years old or less), "remembering when to take ARVs based on the position of the sun" and "feeling pressured to share ARVs with someone" were independent factors for being classified in the non-adherent group. Given the lives of the participants in the study, conditions related to ART might differ from those in urban areas. In fact, more than half of respondents were farmers, about half did not own a watch, and more than one-third did not use a watch or a clock while nearly 10%) used the position of the sun to remember when to take ARVs. It is suggested that PLWH in rural areas had limited ways of knowing the exact time and ways to remember when to take ARVs.

The distance to health care services in particular is longer in rural areas than in urban areas ([@R22]; [@R32]). Therefore the distance to ART services and travel expenses are well-known barriers to optimal adherence in rural areas ([@R14]; [@R24]; [@R27]). However, [@R6] reported that patients in rural Zambia were able to achieve an adherence rate compatible with good clinical outcomes despite long-travel distances. In contrast, we found a trend for high travel expenses to reach ART services to be related to higher odds of classification in the non-adherent group (OR = 2.2, 95%) CI: 0.9--5.2, *p* = 0.06), although it was not significant in multivariable logistic regression analysis probably because of the association with feeling pressured to share ARVs.

###### 

Bivariate logistic regression analysis of correlates of non-adherence.

                                      Missed dose in the past four days                                         
  ----------------------------------- ----------------------------------- ------------- ----------------------- ---------
  Age                                                                                                           
    More than 38 years                13 (24.5%)                          205 (55.2%)   Ref                     
    38 years or less                  40 (75.5%)                          253 (44.8%)   2.493 (1.299--4.787)    0.005
  Gender                                                                                                        
    Male                              15 (28.8%)                          188 (42.3%)   Ref                     
    Female                            37 (71.2%)                          256 (57.7%)   1.812 (0.966--3.401)    0.061
  Marital status                                                                                                
    Single/Divorce/                   30 (57.7%)                          214 (48.5%)   Ref                     
    Widowed                                                                                                     
    Married/Remarried                 22 (42.3%)                          227 (51.5%)   0.691 (0.387--1.236)    0.211
  Duration of ART                                                                                               
    More than 12 months               30 (56.6%)                          276 (60.3%)   Ref                     
    12 months or less                 23 (43.4%)                          182 (39.7%)   1.163 (0.655--2.065)    0.607
  Place of ART                                                                                                  
    District hospital                 24 (45.3%)                          233 (50.9%)   Ref                     
    Rural health center               29 (54.7%)                          225 (49.1%)   1.251 (0.707--2.215)    0.442
  Cost of return trip                                                                                           
    Free of charge                    18 (36.0%)                          204 (44.7%)   Ref                     
    Less than 10,000 Kw               16 (32.0%)                          174 (38.2%)   1.043 (0.516--2.105)    0.908
    More than 10,000 Kw               16 (32.0%)                          78 (17.1%)    2.325 (1.129--4.787)    0.022
  Way to remember when to take ARVs                                                                             
    Watch                             24 (46.2%)                          220 (49.4%)   Ref                     
    Clock                             8 (15.4%)                           68 (15.3%)    1.078 (0.463--2.511)    0.861
    Mobile phone                      2 (3.8%)                            55 (13.4%)    0.333 (0.076--1.453)    0.144
    Radio/Television                  10 (19.2%)                          61 (13.7%)    1.503 (0.062--3.312)    0.312
    Position of the sun               8 (15.4%)                           41 (9.2%)     1.789 (0.245--1.256)    0.189
  Adherence support                                                                                             
    None                              15 (10.3%)                          84 (18.4%)    Ref                     
    Family                            19 (35.8%)                          241 (52.7%)   0.441 (0.215--0.908)    0.026
    Other                             19 (35.8%)                          123 (28.9%)   0.806 (0.388--1.678)    0.563
  Perceived stigma of taking ARVs                                                                               
    Never experienced stigma          37 (71.2%)                          390 (85.2%)   Ref                     
    Experienced stigma                15 (28.8%)                          68 (14.8%)    2.325 (1.210--4.467)    0.011
  Felt pressured to share ARVs                                                                                  
    Never pressured                   36 (69.2%)                          424 (92.8%)   Ref                     
    Felt pressured                    17 (30.8%)                          33 (7.2%)     5.710 (2.872--11.353)   \<0.001

Within the current structure of ARV services, education and information about the importance of taking ARVs at a specific dose time is delivered frequently by health care providers. However, whether this simple instruction is effective for people living in rural areas, like those in the current study, is questionable. Multivariable logistic regression analysis showed that "remembering when to take ARVs based on the position of the sun" was an independent factor associated with higher odds of classification in the non-adherent group although it was not significant in bivariate analysis probably because of the correlation with the adherence support from family member. Health care providers should give rural patients more applicable instructions in accordance with their living conditions. More effective and practical strategies for remembering and cuing dose times to offer patients should be identified and included in the current strategies, and may result in higher adherence in rural areas. In Thailand, for instance, the national anthem, which is played at 8:00 and 18:00 every day on radio and TV, is successfully used as a reminder for patients to take ARVs ([@R30]).

###### 

Multivariable logistic regression analysis of correlates of non-adherence.

                                      Odds ratio (95% CI)     P-value
  ----------------------------------- ----------------------- ---------
  Age                                                         
    More than 38 years                Ref                     
    38 years or less                  2.646 (1.271--5.508)    0.009
  Cost of return trip                                         
    Free of charge                    Ref                     
    Less than 10,000 Kw               1.081 (0.501--2.336)    0.842
    More than 10,000 Kw               2.217 (0.942--5.236)    0.068
  Adherence support                                           
    None                              Ref                     
    Family                            0.538 (0.226--1.282)    0.162
    Other                             1.176 (0.504--2.747)    0.708
  Way to remember when to take ARVs                           
    Watch                             Ref                     
    Clock                             1.477 (0.561--3.891)    0.43
    Mobile phone                      0.654 (0.142--3.012)    0.585
    Radio/Television                  2.252 (0.920--5.525)    0.076
    Position of the sun               3.311 (1.252--8.772)    0.016
  Perceived stigma of taking ARVs                             
    Never experienced stigma          Ref                     
    Experienced stigma                1.06 (0.409--2.747)     0.905
  Felt pressured to share ARVs                                
    Never pressured                   Ref                     
    Felt pressured                    4.390 (1.615--11.933)   0.004

The use of mobile phones has spread rapidly and 18% of participants owned it while they were in rural area in our study. [@R9] reported that telephone call support was an effective way to remember the time and to maintain a desirable level of adherence in a research setting. And automated reminding service using short message service (SMS) is provided and favorably received in some countries. For the people who own the mobile phone, intervention using it could be considered in the future.

Feeling pressured to share ARVs with someone such as a family member or friend, which nearly 10% of the participants experienced, was the strongest factor associated with being classified in the non-adherent group in this study. This can also be an issue for patients on ART in rural areas where ARVs are not easily obtainable. Although participants were not asked if they actually shared their medicine with others, health care providers and counselors need to be aware of this issue and to carefully monitor patients in rural areas. A similar issue was the fear of stigma resulting from taking ARVs at work or home, which was experienced by 16% of participants and significantly associated with being classified in the non-adherent group in bivariate analysis. However, perceived fear of stigma resulting from taking ARVs did not maintain significance in the multivariable analysis, probably because of the high association with feeling pressured to share ARVs with someone as confounding factor. Per Zambian policy, ART patients must choose someone to provide treatment support to maintain high adherence to ART before starting the treatment, and most choose a family member. The issues of feeling pressured to share ARVs with a family member and the fear of stigma resulting from taking ARVs at home should be taken into careful consideration, especially for female patients ([@R17]). Education and counseling of family members should be performed along with careful monitoring of patients by health care providers.

One limitation of this study, however, is that information was not collected from patients who defaulted from treatment or untraceable patients because this was conducted among who came to health facility for treatment. Important findings in relation to adapting ART programs to rural areas may be revealed by determining factors for low adherence from patients lost to follow-up or their reason for withdrawing from treatment.

The percentage of participants who had not missed a dose in the past four days was 88%, which was comparable to results of other studies using similar questions ([@R12]; [@R18]; [@R25]; [@R28]). Although optimal adherence is required for better treatment outcomes for ART, there is still no "golden standard" by which to measure adherence because each methodology has its own advantages and disadvantages ([@R10]; [@R13]; [@R20]). Self-report is most frequently used measure of adherence to ART because it is simple and inexpensive method. In addition, its significant association with virological treatment response has been reported ([@R19]; [@R26]). Therefore, we adopted self-report of missed doses in the past four days to evaluate recent adherence.

As ART services expand to rural areas, information of more specific factors arising in rural settings can help program implementers because they may differ from those in urban settings. Lessons learned in urban settings must be cautiously applied to rural areas because resources are limited in rural areas and because of these factors. The current results show that specific factors related to possible conditions occurring in the daily lives of patients on ART in rural Zambia are likely to affect adherence to treatment.

Conclusion {#s8}
==========

As ART services expand to rural areas, program implementers should pay more attention to more specific factors arising in rural settings since they may differ from those in urban settings. This study conducted in rural area, however, suggested that specific factors such as remembering when to take ARVs based on the position of the sun and feeling pressured to share ARVs with someone, need to be carefully considered along with demographic factors as predictive factors for low adherence.

Acknowledgements {#s9}
================

This study was financially supported by the "International Medical Cooperation Study Fund" managed by the National Center for Global Health and Medicine and was conducted in cooperation with JICA\'s "Integrated HIV/AIDS care service implementation project at the district level," which works together with the Zambian Ministry of Health and Mumbwa District Health Management Team. Data collection was done with the assistance of AMDA Zambia.
